Implementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times.

被引：0
|
作者：
Losk, Katya
Freedman, Rachel A.
Lin, Nancy U.
Golshan, Mehra
Lester, Susan
Pochebit, Stephen
Natsuhara, Kelsey
Camuso, Kristen
King, Tari A.
Bunnell, Craig A.
机构：
[1] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[5] Brigham & Womens Faulkner Hosp, Boston, MA USA
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 08期
关键词：
D O I：
10.1200/JCO.2017.35.8_suppl.166
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
166
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Can Oncotype DX recurrence score (RS) be used in luminal A and luminal B breast cancer patients (pts) to predict the likely benefit of chemotherapy? A retrospective study in the Spanish population
    Garcia-Estevez, Laura
    Contreras, Ana C.
    Calvo, Isabel
    Fernandez Abad, Maria
    de la Cruz, Juan J.
    Perea, Sofia
    Suarez, Ana
    Lopez-Rios, Fernando
    Hidalgo, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] GSTM1 polymorphism in Oncotype DX assay can predict response to taxane-based neoadjuvant chemotherapy in ER-positive Chinese breast cancer patients
    Liao, N.
    Qian, X. K.
    Ren, C. Y.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S55 - S56
  • [43] Influence of age on the indication of adjuvant chemotherapy in early breast cancer using Oncotype DX. An analysis of 240 patients treated in the Institut Catala d'Oncologia (ICO) hospitals
    Recalde, S.
    Quiroga, V.
    del Barco, S.
    Falo, C.
    Dorca, J.
    Margeli, M.
    Stradella, A.
    Soler, T.
    Teruel Garcia, I.
    Vinas, G.
    Fernandez, A.
    Villanueva Vazquez, R.
    Vethencourt, A.
    Romeo Marin, M.
    Gil-Gil, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 70 - +
  • [44] Development and implementation of the MammaPrint® Algorithm (MPA) to reduce chemotherapy overtreatment in South African patients with early stage breast cancer
    Grant, K. A.
    Apffelstaedt, J. P.
    Wright, C.
    Myburgh, E.
    Pienaar, R.
    de Klerk, M.
    Kotze, M. J.
    HISTOPATHOLOGY, 2012, 61 : 20 - 21
  • [45] Trend and survival benefit of Oncotype DX use among female hormone receptor-positive breast cancer patients in 17 SEER registries, 2004-2015
    Zhang, Lu
    Hsieh, Mei-Chin
    Petkov, Valentina
    Yu, Qingzhao
    Chiu, Yu-wen
    Wu, Xiao-Cheng
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 491 - 501
  • [46] Clinical Value Of Oncotype Dx Gene Assay Recurrence Score On Diagnostic Core Biopsy To Predict Response To Neoadjuvant Chemotherapy In Patients With Breast Cancer: Systematic Review And Meta-Analysis
    Al Maksoud, A.
    Boland, M. R.
    Ryan, E. J.
    Balasubramanian, I.
    Evoy, D.
    Geraghty, J.
    McCartan, D.
    Prichard, R. S.
    McDermott, E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (SUPPL 5) : S116 - S117
  • [47] Oncotype DX Breast Recurrence Score Distribution and Chemotherapy Benefit Among Women of Different Age Groups With HR-Positive, HER2-Negative, Node-Negative Breast Cancer in the SEER Database
    Cheng, Ran
    Kong, Xiangyi
    Wang, Xiangyu
    Fang, Yi
    Wang, Jing
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [48] GSTM1 polymorphism in Oncotype DX assay is a potential predictive factor for taxane-based neoadjuvant chemotherapy in estrogen receptor-positive Chinese breast cancer patients
    Zhang, Guochun
    Qian, Xueke
    Ren, Chongyang
    Wen, Lingzhu
    Lyu, Haitong
    Liao, Ning
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (02) : 655 - 663
  • [49] Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage breast cancer (ESBC) patients
    Petrakova, K.
    Petruzelka, L.
    Holanek, M.
    Svoboda, T.
    Benesova, V.
    Palacova, M.
    Kolarova, I.
    Bielcikova, Z.
    Chrapava, M.
    BREAST, 2019, 44 : S16 - S16
  • [50] Prediction of recurrence with the Oncotype DX recurrence score in node-positive, HR-positive, breast cancer patients treated with adjuvant chemotherapy: Results from PACS01 trial.
    Penault-Llorca, Frederique Madeleine
    Filleron, Thomas
    Asselain, Bernard
    Baehner, Frederick L.
    Fumoleau, Pierre
    Lacroix-Triki, Magali
    Butler, Steven M.
    Jamshidian, Farid
    Cherbavaz, Diana B.
    Shak, Steven
    Roca, Lise
    Sagan, Christine
    Lemonnier, J.
    Martin, Anne-Laure
    Roche, Henri Hubert
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345